Journals / Turkish Journal of Obstetrics and Gynecology / 2015 / Cilt: 12 - Sayı: 4

Meme kanseri tanılı olguda tamoksifen tedavisi ile ilişkili uterin Müllerian adenosarkom

Mullerian adenosarcoma of the uterus associated with tamoxifen treatment for breast cancer

Pages
244–247
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The woman is alive and her chemoradiotherapy treatment is ongoing.The role of tamoxifen therapy in the development of endometrial neoplasms remains unclear, but all cases of endometrial thickening and vaginal bleeding must be investigated for Mullerian adenosarcoma in tamoxifen users

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Mullerian adenosarcoma following tamoxifen therapy is a rare condition.
📊
Key Findings & Data:A premenopausal woman aged 38 years who was undergoing tamoxifen therapy for breast cancer, was admitted with symptoms of lower abdominal pain and irregular vaginal bleeding and malodorous vaginal discharge that had continued for at least 6 months.
💡
Conclusion & Impact:The woman is alive and her chemoradiotherapy treatment is ongoing.The role of tamoxifen therapy in the development of endometrial neoplasms remains unclear, but all cases of endometrial thickening and vaginal bleeding must be investigated for Mullerian adenosarcoma in tamoxifen users
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Mullerian adenosarcoma following tamoxifen therapy is a rare condition. Our aim was to report the youngest patient in the literature with uterine mullerian adenosarcoma who was undergoing tamoxifen therapy for breast cancer. A premenopausal woman aged 38 years who was undergoing tamoxifen therapy for breast cancer, was admitted with symptoms of lower abdominal pain and irregular vaginal bleeding and malodorous vaginal discharge that had continued for at least 6 months. A pelvic examination revealed a large and malodorous polypoid mass protruding through the cervix and an enlarged uterus. A biopsy from the protruding polypoid mass was reported as a large area of necrosis with neoplastic mesenchymal cells. The patient underwent a total abdominal hysterectomy, bilateral salpingo-oopherectomy, pelvic-paraaortic lymph node dissection, and omentectomie. The histologic diagnosis was Mullerian adenosarcoma. As a result, she was discharged to the oncology department. The woman is alive and her chemoradiotherapy treatment is ongoing.The role of tamoxifen therapy in the development of endometrial neoplasms remains unclear, but all cases of endometrial thickening and vaginal bleeding must be investigated for Mullerian adenosarcoma in tamoxifen users

Özet

Meme kanseri tanılı olgularda tamoksifen tedavisine bağlı uterin Müllerian adenosarkom gelişimi nadir bir durumdur. Amacımız literatürde meme kanseri tanılı, tamoksifen tedavisine bağlı uterin müllerian adenosarkom gelişmiş en genç kadın hastayı rapor etmektir. Meme kanseri tedavisi için tamoksifen kullanan 38 yaşında premenapozal kadın hasta son 1-1,5 yıldır devam eden alt batın ağrısı, anormal vajinal kanama ve kötü kokulu vajinal akıntı tariflemektedir. Pelvik muayenede serviksten dışarı doğru uzanan ve uterusu büyüten büyük, kötü kokulu polipoid yapı izlendi. Polipoid yapıdan alınan biyopsi örneklerinde geniş nekroz alanları ve neoplastik mezenşimal hücreler tespit edildi. Hastaya total abdominal histerektomi, bilateral salpingoooferektomi, pelvik ve paraaortik lenf nodu disseksiyonu ve omentektomi yapıldı. Histolojik olarak Müllerian adenosarkom tanısı kondu ve hasta onkoloji bölümüne yönlendirildi. Hasta hala yaşıyor olup kemoterapi almaktadır. Endometrial tümörlerinin gelişiminde tamoksifen tedavisinin rolü belirsizdir, ama endometriyal kalınlaşma ve vajinal kanaması olan tamoksifen kullanan hastaların Müllerian adenosarkom açısından araştırılması gerekir.

🔖

Cite This Article

CEYLAN, Y., DOĞER, E., ÇAKIROĞLU, A. Y., VURAL, Ç., YÜCESOY, İ. (2015). Meme kanseri tanılı olguda tamoksifen tedavisi ile ilişkili uterin Müllerian adenosarkom. Turkish Journal of Obstetrics and Gynecology, Cilt: 12 - Sayı: 4, 244–247. https://ajindex.com/articles/376460

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Friedlander ML, Covens A, Glasspool RM, Hilpert F, Kristensen G, Kwon S, et al. Gynecologic Cancer InterGroup (GCIG) consensus review for mullerian adenosarcoma of the female genital tract. Int J Gynecol Cancer 2014;24(9 Suppl 3):78-82.
  2. Clement PB, Oliva E, Young RH. Mullerian adenosarcoma of the uterine corpus associated with tamoxifen therapy: a report of six cases and a review of tamoxifen-associated endometrial lesions. Int J Gynecol Pathol 1996;15:222-9.
  3. Bocklage T, Lee KR, Belinson JL. Uterine mullerian adenosarcoma following adenomyoma in a woman on tamoxifen therapy. Gynecol Oncol 1992;44:104-9.
  4. Jessop FA, Roberts PF. Müllerian adenosarcoma of the uterus in association with tamoxifen therapy. Histopathology 2000;36:91-2.
  5. Jagavkar RS, Shakespeare TP, Stevens MJ. Endometrial adenosarcoma with adjuvant tamoxifen therapy for primary breast carcinoma. Australas Radiol 1998;42:157-8.
  6. Arici DS, Aker H, Yildiz E, Tasyurt A. Mullerian adenosarcoma of the uterus associated with tamoxifen therapy. Arch Gynecol Obstet. 2000;264:105-7.
  7. Chourmouzi D, Boulogianni G, Zarampoukas T, Drevelengas A. Sonography and MRI of tamoxifen-associated müllerian adenosarcoma of the uterus. AJR Am J Roentgenol 2003;181:1673-5.
  8. Soh E, Eleti A, Jimenez-Linan M, Arends MJ, Latimer J, Sala E. Magnetic resonance imaging findings of tamoxifen-associated uterine Müllerian adenosarcoma: a case report. Acta Radiol 2008;49:848-51.
  9. Kennedy MM, Baigrie CF, Manek S. Tamoxifen and the endometrium: review of 102 cases and comparison with HRT- related and non-HRT-related endometrial pathology. Int J Gynecol Pathol 1999;18:130-7.
  10. Seidman JD, Wasserman CS, Aye LM, MacKoul PJ, O'Leary TJ. Cluster of uterine mullerian adenosarcoma in the Washington, DC metropolitan area with high incidence of sarcomatous overgrowth. Am J Surg Pathol 1999;23:809-14.
  11. Farhat F, Fakhruddine N. A case of synchronous relapse of breast cancer and uterine müllerian adenosarcoma post tamoxifen in a premenopausal woman. Eur J Gynaecol Oncol 2008;29:95-7.
  12. Carroll A, Ramirez PT, Westin SN, Soliman PT, Munsell MF, Nick AM, et al. Uterine adenosarcoma: an analysis on management, outcomes, and risk factors for recurrence. Gynecol Oncol 2014;135:455-61.